menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Reviewing New Therapies for Hidradenitis Suppurative 

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Two of the biggest trials were recently completed for the use of IL-17 inhibitors for treating hidradenitis suppurative (HS). So what data should we know about? In this episode, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Two of the biggest trials were recently completed for the use of IL-17 inhibitors for treating hidradenitis suppurative (HS). So what data should we know about? In this episode, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.

Facebook Comments

Schedule19 Jun 2024